Clinical Trials
1
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Pregnancy and Neonatal Outcomes Following Antenatal Exposure to Raltegravir: a Pooled Analysis From the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)
- First Posted Date
- 2023-03-02
- Last Posted Date
- 2023-03-02
- Lead Sponsor
- Fondazione Penta UK
- Target Recruit Count
- 1200
- Registration Number
- NCT05751031
- Locations
- 🇧🇪
Centre Hospitalier Universitaire Saint Pierre, Brussels, Belgium
🇮🇹Università degli studi di Firenze, Firenze, Italy
🇷🇴"Victor Babes" Hospital, Bucharest, Romania
News
No news found